Clinical trial for the efficacy of CJ_AJ on blood circulatio
- Conditions
- Not Applicable
- Registration Number
- KCT0001031
- Lead Sponsor
- Ajou University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 42
1) Male adult smokers more than 10 cigarettes per day
2) Platelet eggregation results > 70% at screening
3) Wiling to provide own written informed consent to trial participation
1) Intake of any prescription drug for myocardial infarction, angina or bleeding disorders
2) Intake of aspirin, anti-coagulants or anti-platelet agents within 2 weeks prior to screening
3) Intake of red ginseng, ginseng, fermented bean paste within 2 weeks prior to screening
4) Uncontrolled hypertension (systolic blood pressure > 160 mmHg or diastolic blood pressure > 100 mmHg)
5) Uncontrolled diabetes mellitus (fasting glucose > 180mg/dl, or intake of hypoglycemic agents within 3 months prior to screening)
6) Uncontrolled thyroid diseases
7) Surgery under general anesthesia within 3 months prior to screening
8) Serum creatinine > 2 x upper normal limit
9) Serum alanine Transaminase, aspartate Transaminase > 3 x upper normal limit
10) Subject with severe epigastric soreness or indigestion
11) Participation of other clinical study within 3 months prior to screening
12) Ineligible for study participation due to other reasons, according to the investigator’s judgment
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Platelet aggregation test
- Secondary Outcome Measures
Name Time Method Serotonin;Thromboxane B2;C-reactive protein;Coagulation tests;Lipid panel